NFATC1 and osteoporosis: In the present research, we focused on the potential therapeutic effects of LrB on RANKL-induced osteoclast activity in vitro and an ovariectomy (OVX)-induced osteoporosis mouse model in vivo, and evaluated the effect of LrB on ROS, NFATc1 and MAPK pathways to elucidate the underlying mechanisms.